CEREBRO Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

CEREBRO Therapeutics General Information

Description

Developer of a non-invasive therapeutic strategy designed for neurodegenerative disorders. The company utilizes single-chain variable fragment development, viral vector delivery, immunotherapy, gene therapy, protein aggregation prevention, and non-invasive brain targeting, enabling patients with neurodegenerative disorders to access treatments that block disease progression and preserve quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 2601 Avenue de la Canardière
  • Quebec city, Quebec
  • Canada
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Vertical(s)
Corporate Office
  • 2601 Avenue de la Canardière
  • Quebec city, Quebec
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CEREBRO Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 25-Nov-2025 Completed Startup
1. Angel (individual) 30-Oct-2025 Completed Startup
To view CEREBRO Therapeutics’s complete valuation and funding history, request access »

CEREBRO Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CEREBRO Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Capital BioVentures Accelerator/Incubator
To view CEREBRO Therapeutics’s complete investors history, request access »

CEREBRO Therapeutics FAQs

  • When was CEREBRO Therapeutics founded?

    CEREBRO Therapeutics was founded in 2022.

  • Where is CEREBRO Therapeutics headquartered?

    CEREBRO Therapeutics is headquartered in Quebec city, Canada.

  • What is the size of CEREBRO Therapeutics?

    CEREBRO Therapeutics has 6 total employees.

  • What industry is CEREBRO Therapeutics in?

    CEREBRO Therapeutics’s primary industry is Biotechnology.

  • Is CEREBRO Therapeutics a private or public company?

    CEREBRO Therapeutics is a Private company.

  • What is CEREBRO Therapeutics’s current revenue?

    The current revenue for CEREBRO Therapeutics is .

  • Who are CEREBRO Therapeutics’s investors?

    Capital BioVentures has invested in CEREBRO Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process